Log in to save to my catalogue

Inflammasome activation at the crux of severe COVID-19

Inflammasome activation at the crux of severe COVID-19

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8351223

Inflammasome activation at the crux of severe COVID-19

About this item

Full title

Inflammasome activation at the crux of severe COVID-19

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Immunology, 2021-11, Vol.21 (11), p.694-703

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), results in life-threatening disease in a minority of patients, especially elderly people and those with co-morbidities such as obesity and diabetes. Severe disease is characterized by dysregulated cytokine release, pneumonia and acute lung injury, which c...

Alternative Titles

Full title

Inflammasome activation at the crux of severe COVID-19

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8351223

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8351223

Other Identifiers

ISSN

1474-1733,1474-1741

E-ISSN

1474-1741

DOI

10.1038/s41577-021-00588-x

How to access this item